Oral Biotherapeutic ADS024 Safe, Tolerable for Recurrent C difficile Prevention
New phase 1B data support further investigation into Adiso Therapeutic's prospective treatment.
Source: ajmc.com
Page 3 - C Difficile News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from C Difficile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In C Difficile Today - Breaking & Trending Today
Better Fecal Live Microbiota Outcomes Linked to Gut Microbiome Health
New PUNCH CD3 analyses show patients who were treated with live fecal microbiota therapy improved their gut health at 8 weeks—which correlated with improved quality-of-life scores.
Source: hcplive.com
Paul Feuerstadt, MD: Preventing Recurrent C Difficile in Older Adults with Comorbidities
Feuerstadt reviews ACG 2023 data showing live microbiota therapy provides consistent protection against rCDI in one of the most vulnerable patient populations.
Source: hcplive.com
Live Microbiota Therapy Prevents Recurrent CDI in Older Adults with Comorbidity
New data presented at ACG 2023 showed an approximate 60% success rate of recurrent C difficile prevention in adults with comorbid conditions including CKD and cardiac disease.
Source: hcplive.com
Examining the Impact of Enhanced Infection Prevention Measures on HAIs, Including CLABSIs
In an interview with Amy Spallone, MD, from The University of Texas MD Anderson Cancer Center, the study investigates the effects of COVID-19 precautions on healthcare-associated infections, revealing surprising results in central line-associated bloodstream infections (CLABSIs), C difficile infections, and more.
Source: infectioncontroltoday.com